NCT02821507View on ClinicalTrials.gov

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Conventional ChondrosarcomaMyxoid LiposarcomaMesenchymal ChondrosarcomaDedifferentiated Chondrosarcoma
Interventions
DRUG

sirolimus and cyclophosphamide

Trial Locations (7)

2333ZA

LUMC, Leiden

Unknown

Hospital de Sant Pau, Barcelona

Hospital Val d'Hebron, Barcelona

CIO Clara Campal, Madrid

Hospital Universitario Virgen del Rocío, Seville

Hospital Universitario y Politécnico de La Fe, Valencia

Instituto Valenciano de Oncología, Valencia

All Listed Sponsors
lead

Leiden University Medical Center

OTHER

NCT02821507 - Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | Biotech Hunter | Biotech Hunter